Status:

COMPLETED

Effects of DigiVibe on Pain in Subjects Undergoing Intramuscular Injections, Subcutaneous Injections, and Fingersticks

Lead Sponsor:

East Coast Institute for Research

Collaborating Sponsors:

Universal Axon Clinical Research, LLC

Suthe Dermal

Conditions:

Healthy

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This is a single-center, unblinded, prospective, cross-over study. The study population will include twenty (n=20) healthy subjects (10 men and 10 women) over the age of 18 with a self-reported fear/d...

Detailed Description

While the complete mechanisms of pain and pain diversion are not completely understood, DigiVibe locally targets the skin's pain receptors. Therefore, it is proposed that the vibrations from the DigiV...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years
  • BMI 18.5-29.9 kg/m2 (normal)
  • Self-reported fear/dislike of needles

Exclusion

  • Chronic (daily) use of nonsteroidal anti-inflammatory drugs (NSAIDs) (i.e. ibuprofen, aspirin, naproxen, etc.), antiplatelet medications (i.e. clopidogrel, prasugrel, ticagrelor, cangrelor, cilostazol, etc), or anticoagulant medications (i.e. warfarin, dabigatran, rivaroxaban, apixaban, edoxaban, heparin, enoxaparin, fondaparinux, etc.)
  • Note: NSAIDs used as needed are not excluded as long as they are not used within 3 days of study screening and enrollment
  • Chronic (daily) use of analgesics (i.e. acetaminophen, NSAIDs \[ie. ibuprofen, naproxen\], opioids \[ie. morphine, oxycodone, fentanyl\], lidocaine, cannabinoids \[ie. CBD, THC\],)
  • Note: analgesics used as needed are not excluded as long as they are not used within 3 days of study screening and enrollment
  • Any condition in the opinion of the study investigator that would potentially confound the results of this study

Key Trial Info

Start Date :

August 4 2025

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 15 2025

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT06987201

Start Date

August 4 2025

End Date

August 15 2025

Last Update

September 25 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Universal Axon Clinical Research, LLC

Doral, Florida, United States, 33166